menu search

Tempest Adopts Limited Duration Stockholder Rights Plan

Tempest Adopts Limited Duration Stockholder Rights Plan
BRISBANE, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-classi therapeutics that combine both targeted and immune-mediated mechanisms, today announced that its Board of Directors (the “Board”) has adopted a limited duration stockholder rights plan, effective immediately (the “Rights Plan”). Stephen Brady, president and chief executive […] The post Tempest Adopts Limited Duration Stockholder Rights Plan ap... Read More
Posted: Oct 11 2023, 12:01
Author Name: forextv
Views: 092069

Search within

Pages Search Results: